2 completed, 1 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Terminated 1 |
Follow Phenergan: new trials by email Literature Review of Phenergan trials Research Report on Phenergan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease Fluconazole, Vancomycin, Neomycin - Crohn's Disease | Phase 2 | Completed | University of Pennsylvania | 8 | 2016-08-01 | 2024-02-06 |
| Study of Promethazine for Treatment of Diabetic Gastroparesis Promethazine, Sugar pill - Diabetic Gastroparesis | Phase 2 | Terminated | Dartmouth-Hitchcock Medical Center | 3 | 2014-07-01 | 2018-08-07 |
| Sunitinib or Cediranib for Alveolar Soft Part Sarcoma Cediranib, Sunitinib, Prochlorperazine - Sarcoma, Alveolar Soft Part | Phase 2 | Completed | National Cancer Institute (NCI) | 34 | 2011-07-18 | 2026-02-02 |
Crohn Disease (1) · Sarcoma, Alveolar Soft Part (1)
Dartmouth-Hitchcock Medical Center (1) · National Cancer Institute (NCI) (1) · University of Pennsylvania (1)
United States (3)
Alice P Chen, M.D. (1) · Brian E. Lacy, MD (1) · James D Lewis, MD, MSCE (1) · Lindsey Albenberg, DO (1)